NYSE:VARVarian Medical Systems Stock Price, Forecast & News

$121.95

+0.21 (+0.17 %)

(As of 05/28/2020 10:05 AM ET)

Add

Compare

Today's Range

$121.95

Now: $121.95▼

$123.53

50-Day Range

$104.10

MA: $113.43▼

$121.36

52-Week Range

$89.62

Now: $121.95▼

$150.06

Volume1,573 shs

Average Volume767,045 shs

Market Capitalization$11.08 billion

P/E Ratio44.83

Dividend YieldN/A

Beta1.07

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions; and a strategic cooperation framework agreement with Shandong Cancer Hospital for proton therapy clinical application and research in China. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Beat the Market (BTM) Rank^™

2.2 Analyst's Opinion

Consensus Rating
Varian Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 5 buy ratings, 1 hold rating, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $125.25, Varian Medical Systems has a potential upside of 2.9% from its current price of $121.74.
Amount of Analyst Coverage
Varian Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.7 Community Rank

Outperform Votes
Varian Medical Systems has received 539 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Varian Medical Systems has received 470 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Varian Medical Systems has received 53.42% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote “Outperform” if you believe VAR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Varian Medical Systems does not currently pay a dividend.
Dividend Growth
Varian Medical Systems does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Varian Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,279,990.00 in company stock.
Percentage Held by Insiders
Only 0.78% of the stock of Varian Medical Systems is held by insiders.
Percentage Held by Institutions
90.90% of the stock of Varian Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Varian Medical Systems are expected to grow by 40.28% in the coming year, from $3.60 to $5.05 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Varian Medical Systems is 44.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of Varian Medical Systems is 44.76, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.08.
Price to Earnings Growth Ratio
Varian Medical Systems has a PEG Ratio of 4.11. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Varian Medical Systems has a P/B Ratio of 5.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.55 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Electromedical equipment

Sub-IndustryHealth Care Equipment

SectorMedical

Current SymbolNYSE:VAR

Previous Symbol

CUSIP92220P10

CIK203527

Webwww.varian.com

Phone650-493-4000

Debt

Debt-to-Equity Ratio0.05

Current Ratio1.28

Quick Ratio0.97

Price-To-Earnings

Trailing P/E Ratio44.83

Forward P/E Ratio33.88

P/E Growth4.11

Sales & Book Value

Annual Sales$3.23 billion

Price / Sales3.43

Cash Flow$5.86 per share

Price / Cash Flow20.81

Book Value$20.60 per share

Price / Book5.92

Profitability

EPS (Most Recent Fiscal Year)$4.63

Net Income$291.90 million

Net Margins7.51%

Return on Equity22.93%

Return on Assets9.88%

Miscellaneous

Employees10,062

Outstanding Shares90,820,000

Market Cap$11.08 billion

Next Earnings Date7/22/2020 (Estimated)

OptionableOptionable

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VAR shares have increased by 7.7% and is now trading at $121.74. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Varian Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Varian Medical Systems.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Varian Medical Systems.

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its quarterly earnings data on Monday, May, 4th. The medical equipment provider reported $0.85 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.85. The medical equipment provider had revenue of $794.50 million for the quarter, compared to the consensus estimate of $769.99 million. Varian Medical Systems had a net margin of 7.51% and a return on equity of 22.93%. The business's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.05 earnings per share. View Varian Medical Systems' earnings history.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its second quarter 2020 Pre-Market earnings guidance on Monday, March, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $800-825 million, compared to the consensus revenue estimate of $871.75 million.

What price target have analysts set for VAR?

8 brokerages have issued 12-month price targets for Varian Medical Systems' shares. Their forecasts range from $90.00 to $150.00. On average, they expect Varian Medical Systems' share price to reach $125.25 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price. View analysts' price targets for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Economic stagnation due to coronavirus outbreak has been another dampener. Reflective of these, the stock has underperformed the industry in a year’s time. Varian exited the fiscal first quarter on a weak note." (4/10/2020)
2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)

Has Varian Medical Systems been receiving favorable news coverage?

News headlines about VAR stock have trended somewhat negative this week, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Varian Medical Systems earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutVarian Medical Systems.

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,020,000 shares, an increase of 21.8% from the April 15th total of 2,480,000 shares. Based on an average trading volume of 909,300 shares, the short-interest ratio is currently 3.3 days. Currently, 3.3% of the shares of the company are short sold. View Varian Medical Systems' Current Options Chain.

Who are some of Varian Medical Systems' key competitors?

Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Masimo (MASI). View all competitors.

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T), Thermo Fisher Scientific (TMO), Visa (V), Align Technology (ALGN), Intel (INTC), Pfizer (PFE) and Verizon Communications (VZ).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:

Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
Mr. Kevin O'Reilly, Sr. VP of Global Operations

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.42%), State Street Corp (4.65%), Fiera Capital Corp (3.68%), Loomis Sayles & Co. L P (3.44%), Wells Fargo & Company MN (2.64%) and Wellington Management Group LLP (2.33%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View institutional ownership trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Schroder Investment Management Group, Janus Henderson Group PLC, AQR Capital Management LLC, Smith Asset Management Group LP, Loomis Sayles & Co. L P, Alberta Investment Management Corp, and Pictet Asset Management Ltd.. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert, and Timothy E Guertin. View insider buying and selling activity for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Mackenzie Financial Corp, Viking Global Investors LP, DSM Capital Partners LLC, AXA, Frontier Capital Management Co. LLC, APG Asset Management N.V., and APG Asset Management N.V.. View insider buying and selling activity for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $121.74.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $11.06 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff